Elevated Expression of miR-210 Predicts Poor Survival of Cancer Patients: A Systematic Review and Meta-Analysis

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

(2014) Allen S. Ho et al.   Translational Oncology

miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis

(2013) R I McCormick et al.   BRITISH JOURNAL OF CANCER

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients

(2013) Shuwei Qiu et al.   Journal of Translational Medicine

Survival of hypoxic human mesenchymal stem cells is enhanced by a positive feedback loop involving miR-210 and hypoxia-inducible factor 1

(2013) Woochul Chang et al.   Journal of Veterinary Science

Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma

(2013) Haiqing Cai et al.   MEDICAL ONCOLOGY

TLR3-Induced Placental miR-210 Down-Regulates the STAT6/Interleukin-4 Pathway

(2013) Shelley E. Kopriva et al.   PLoS One

miR-210 suppresses BNIP3 to protect against the apoptosis of neural progenitor cells

(2013) Fei Wang et al.   Stem Cell Research

MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines

(2013) S Grosso et al.   Cell Death & Disease

Diagnostic and prognostic potential of differentially expressed miRNAs between metastatic and non-metastatic renal cell carcinoma at the time of nephrectomy

(2012) Zofia Wotschofsky et al.   CLINICA CHIMICA ACTA

Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer

(2012) D. Madhavan et al.   CLINICAL CANCER RESEARCH

Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma

(2012) An Zhao et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

miR-210: a therapeutic target in cancer

(2012) Liu Hong et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy

(2012) Elrasheid A. H. Kheirelseid et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

High Expression of MicroRNA-210 is an Independent Factor Indicating a Poor Prognosis in Japanese Triple-negative Breast Cancer Patients

(2012) T. Toyama et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Up-regulation of miR-210 by vascular endothelial growth factor inex vivoexpanded CD34+ cells enhances cell-mediated angiogenesis

(2012) Mohamad Amer Alaiti et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Survivin-miRNA-loaded nanoparticles as auxiliary tools for radiation therapy: preparation, characterisation, drug release, cytotoxicity and therapeutic effect on colorectal cancer cells

(2012) Sebastian Gaca et al.   JOURNAL OF MICROENCAPSULATION

Expression of miRNAs Involved in Angiogenesis, Tumor Cell Proliferation, Tumor Suppressor Inhibition, Epithelial-Mesenchymal Transition and Activation of Metastasis in Bladder Cancer

(2012) Apostolos Zaravinos et al.   JOURNAL OF UROLOGY

miR-210 activates notch signaling pathway in angiogenesis induced by cerebral ischemia

(2012) Yuan-Lei Lou et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA

(2012) S. Volinia et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Expression of miR-210 during erythroid differentiation and induction of γ-globin gene expression

(2011) Nicoletta Bianchi et al.   BMB Reports

MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer

(2011) Jelena Radojicic et al.   CELL CYCLE

Circulating miR-210 Predicts Survival in Critically Ill Patients with Acute Kidney Injury

(2011) J. M. Lorenzen et al.   Clinical Journal of the American Society of Nephrology

Expression of microRNA 210 associates with poor survival and age of tumor onset of soft-tissue sarcoma patients

(2011) T. Greither et al.   INTERNATIONAL JOURNAL OF CANCER

A Specific miRNA Signature Correlates With Complete Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

(2011) Giuseppina Della Vittoria Scarpati et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Overexpression of miR-210, a downstream target of HIF1α, causes centrosome amplification in renal carcinoma cells

(2011) Chisato Nakada et al.   JOURNAL OF PATHOLOGY

miR-210: The Master Hypoxamir

(2011) YUK C. CHAN et al.   MICROCIRCULATION

Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer

(2011) Françoise Rothé et al.   PLoS One

The VHL-dependent regulation of microRNAs in renal cancer

(2010) Calida S Neal et al.   BMC Medicine

miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer

(2010) Antonis Giannakakis et al.   CANCER BIOLOGY & THERAPY

MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT

(2010) Zhan Zhang et al.   CELL CYCLE

miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity

(2010) M-P Puisségur et al.   CELL DEATH AND DIFFERENTIATION

MicroRNA-210 as a Novel Therapy for Treatment of Ischemic Heart Disease

(2010) S. Hu et al.   CIRCULATION

MicroRNA-210 Regulates Cancer Cell Proliferation through Targeting Fibroblast Growth Factor Receptor-like 1 (FGFRL1)

(2010) Soken Tsuchiya et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression

(2010) Z Chen et al.   ONCOGENE

Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds

(2010) S. Biswas et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MicroRNA Regulation of DNA Repair Gene Expression in Hypoxic Stress

(2009) M. E. Crosby et al.   CANCER RESEARCH

Rad52

(2009) Uffe H. Mortensen et al.   CURRENT BIOLOGY

miR-210 promotes osteoblastic differentiation through inhibition ofAcvR1b

(2009) Yosuke Mizuno et al.   FEBS LETTERS

Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival

(2009) Thomas Greither et al.   INTERNATIONAL JOURNAL OF CANCER

Ischemic Preconditioning Augments Survival of Stem Cells via miR-210 Expression by Targeting Caspase-8-associated Protein 2

(2009) Ha Won Kim et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

An Integrated Approach for Experimental Target Identification of Hypoxia-induced miR-210

(2009) Pasquale Fasanaro et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation

(2009) Xin Huang et al.   MOLECULAR CELL

Identification of a MicroRNA Panel for Clear-cell Kidney Cancer

(2009) David Juan et al.   UROLOGY

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

(2008) Charles H. Lawrie et al.   BRITISH JOURNAL OF HAEMATOLOGY

hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer

(2008) C. Camps et al.   CLINICAL CANCER RESEARCH

MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3

(2008) Pasquale Fasanaro et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MicroRNAs and the skin: Tiny players in the body's largest organ

(2008) Michael Sand et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Iron–sulfur cluster biogenesis and human disease

(2008) Tracey A. Rouault et al.   TRENDS IN GENETICS